Tradestie Institutional Equity Comparison Engine
UOCT vs UNOV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UNOV Overall Edge
UNOV Captures Institutional Edge (1โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) driven by superior Momentum & Technical. Fundamentally, UOCT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus UNOV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, UOCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
UOCT N/M vs UNOV N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
UNOV
1Y +8.6% vs +9.5% ยท 52W Pos 77% vs 84%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
UOCT
Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - October
Institutional Equity
$41.76
-1.09% 1D
Market Cap
N/A
1M Return
-1.76%
1Y Return
+8.64%
Forward P/E
N/M
Unified AI Score
57.2 / 100
HOLD
Tech 48.0
Fund 60.0
Flow 50.0
Mom 50.0
UNOV
Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap
N/A
1M Return
-0.97%
1Y Return
+9.53%
Forward P/E
N/M
Unified AI Score
58.7 / 100
HOLD
Tech 48.0
Fund 60.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UOCT +8.64%
UNOV +9.53%
Spread: +0.89 pp (UNOV Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UOCT TTM Op. Margin: N/A
UNOV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UOCT vs UNOV. Trailing 12-month operating profitability (UOCT N/A vs UNOV N/A) and valuation multiples (UOCT N/M vs UNOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UOCT | UNOV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 77% ($38โ$43) | 84% ($37โ$42) | Stronger Trend | UNOV |
| Beta / 30D Volatility Risk Regime | 0.42ฮฒ ยท 12% Vol | 0.46ฮฒ ยท 11% Vol | Lower Realized Risk | UNOV |
| Unified Institutional Score Composite Signal | 57.2 / 100 (HOLD) | 58.7 / 100 (HOLD) | Higher Composite | UNOV |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UOCT vs UNOV Buy Guide
UOCT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
UNOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UOCT nor UNOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.